NovaBay Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
NBY NovaBay Pharmaceuticals Inc
EYES Second Sight Medical Products Inc
MCBS MetroCity Bankshares Inc
GNBT Generex Biotechnology Corp
XOM Exxon Mobil Corp
T AT&T Inc
BAC Bank of America Corp
VTI Vanguard Total Stock Market Index Fund ETF Shares
GE General Electric Co
AAL American Airlines Group Inc
Go

Health Care : Pharmaceuticals | Small Cap GrowthCompany profile

NovaBay Pharmaceuticals, Inc., formerly NovaCal Pharmaceuticals, Inc., is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is an eye care product formulated with a form of hypochlorous acid called Neutrox. Its Avenova with Neutrox removes debris from the skin on the eyelids and lashes without burning or stinging. It develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. Its Aganocide compounds, led by auriclosene (NVC-422), are synthetic molecules with activity against bacteria, viruses and fungi. The Company's dermatology product includes CelleRx, a cleansing solution for post laser resurfacing, chemical peels and other cosmetic surgery procedures. Its wound care business includes the business of NeutroPhase product.

Postmarket

Last Trade
Delayed
$0.691
0.001 (0.14%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$0.69
Day's Change
-0.01 (-1.43%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.7294
Day's Low
0.68
Volume
(Light)
Volume:
225,600

10-day average volume:
369,569
225,600
  • Prev Close
    0.70
  • Today's Open
    0.702
  • Day's Range
    0.68-0.7294
  • Avg Vol (10-day)
    369.6K
  • Last (time)
    4:10p ET 08/20/19
  • Last (size)
    1
  • 52-Wk Range
    0.229 - 4.04
    LowHigh
  • (05/13/19 - 06/11/19)
    201.31%
  • 291.2%
  • Market Cap
    14.5M
  • Shares Outstanding
    21.0M
  • -0.54
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 4.8
  • 10.45
  • (% of float 07/31/19)
    8.54

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.